In January 1977, Robert
Edward stated: The storage of human pre-implantation embryos at lower
temperature could be valuable in clinical practice for the cure of infertility
and possibly to avert inherited defects in children. The same author suggested
that it might be beneficial to cryopreserve human oocytes. Since the birth of
Louise Brown in 1978, more than one million children have been born as a result
of assisted reproductive techniques. Although difficult to document specific
numbers, it has been estimated that tens of thousands of children have
developed from embryos that had been cryopreserved.
In 1985, ice-free
cryopreservation of mouse embryos at -196°C by vitrification was reported as an
alternative approach to traditional slow-cooling/rapid-thaw protocols,
vitrification techniques have entered more and more the mainstream of animal
reproduction. In addition, the last few years have seen a significant revival
of interest in the potential benefits of vitrification protocols and techniques
in human-assisted reproductive technologies.
The cryopreservation of
human oocytes, zygotes, early cleavage-stage embryos, and blastocysts has
become an integral part of almost every human in vitro fertilization (IVF)
program. Since the first report of human pregnancy following cryopreservation,
thawing, and transfer of an 8-cell embryo (1), IVF centers have been using
traditional slow-rate or equilibrium freezing protocols fairly successfully.
The time taken to complete these freezing procedures for human embryos ranges
from 90 minutes to 5 hours. Freezing includes the precipitation of water as
ice, with the resulting separation of the water from the dissolved substances.
Both intracellular ice crystal formation and the high concentration of
dissolved substances pose problems. Therefore, a slow rate of cooling attempts
to maintain a very delicate balance between those factors that may result in
damage, mostly by ice crystallization but also by osmotic and chilling injury,
zona and blastomere fracture, and alterations of the cytoskeleton.
Many studies have been
undertaken to reduce the time of the freezing procedure and to try to eliminate
the cost of expensive, programmable freezing equipment. One way to avoid ice
crystallization damage is through the use of vitrification protocols. These
cryopreservation methods present an alternative to conventional freezing with
equilibration.
The
strategy behind vitrification is more radical: a total elimination of ice
formation, then an attempt to reduce toxic and osmotic changes. The physical
process of vitrification can be defined as the glass like solidification of
solutions at low temperate, without ice crystal formation. This phenomenon
could be achieved by increasing the concentration of the cryoprotectant, and/or
increasing cooling and warming rates. Other factors that may facilitate
vitrification include decreasing the volume of the solutions and increasing the
hydrostatic pressure, although the latter has a very few practical consequences
in embryology.
Vitrification techniques
are mainly used for the cryopreservation of oocytes or blastocysts. The late
interest of the technique could be explained by the apprehension of many
researchers to expose embryos to high concentrations of cryoprotectants (30% to
50%) necessary to obtain a vitrified state.
As
early as 1985, ice crystal-free cryopreservation of mouse embryos at -196°C by
vitrification was initially reported (2) in an attempted alternative approach
to cryostorage. Approximately 8 years later, the successful vitrification of
mouse embryos was demonstrated (3).
In 1996,
Martino et al. (4) showed that by using high cooling rates, bovine oocytes
after vitrification are still able to develop to the blastocyst stage. With
the introduction of open-pulled straws in 1997,
the successful vitrification of early stage bovine in vitro-produced embryos
was reported (5).
In
the field of assisted reproductive technologies (ART) in 1999 and 2000,
successful pregnancies and deliveries following vitrification techniques and
protocols for human oocytes have been reported (6,7). Since this time, the
number of scientific publications concerning vitrification has clearly risen.
Vitrification in nature
Although most living
organisms are composed of large amounts of water, it is not inevitable that
freezing these organisms results in ice-formation. Among amphibians and insects
that can tolerate freezing, there is wide variation in the amount of freezing
they can tolerate (8). Woolly bear caterpillars "may spend 10 months of
the year frozen solid at temperatures that descend to 50oC. Species
of frogs can spend days or weeks with as much as 65 percent of their total body
water as ice. Some amphibians achieve their protection due to the glycerol
manufactured by their livers. Glycerol is "antifreeze", it reduces
ice formation and lowers freezing point. Such substances are called
"cryoprotectants". The sugar glucose is also a cryoprotectant and
arctic frogs have a special form of insulin that accelerates glucose release
and absorption into cells as temperatures approach freezing. A cryoprotectant
can make water harden like glass, with no crystal formation. That phenomenon is
called vitrification.
The glycerol, sugars,
and other cryoprotectants which are produced naturally in these organisms, are
not found in levels that adequately explain (with current knowledge of
cryobiology) the remarkable freezing-tolerance. Experiments with cryoprotectants
in mammals in the laboratory still produce results far inferior to those
observed in nature in frogs and insects.
Approaching Vitrification
Time travel is a solved
problem. Einstein showed that if you travel in a spaceship for months at speeds
close to the speed of light, you can return to earth centuries in the future.
Unfortunately for would-be time travelers, such spacecraft will not be
available until centuries in the future.
Rather than Einstein,
nature relies on Arrhenius to achieve time travel. The Arrhenius equation of
chemistry describes how chemical reactions slow down as temperature is reduced.
Since life is chemistry, life itself slows down at cooler temperatures.
Hibernating animals use this principle to time travel from summer to summer,
skipping winters when food is scarce.
Medicine already uses
this kind of biological time travel. When transplantable organs such as hearts
or kidneys are removed from donors, the organs begin dying as soon as their
blood supply stops. Removed organs have only minutes to live. However with
special preservation solutions and cooling in ice, organs can be moved across
hours of time and thousands of miles to waiting recipients. Cold slows chemical
processes that would otherwise be quickly fatal.
Some surgeries on major
blood vessels of the heart or brain can only be done if blood circulation
through the entire body is stopped (9,10). Stopped blood circulation would
ordinarily be fatal within 5 minutes, but cooling to +16°C (60°F) allows the
human body to remain alive in a "turned off" state for up to 60
minutes (11). With special blood substitutes and further cooling to a
temperature of 0°C (32°F), life without heartbeat or circulation can be
extended as much as three hours (12).
Life is chemistry. When
the chemistry of life is adequately preserved, so is life. Preserving the
chemistry of life for unlimited periods of time requires cooling below -130°C
(-200°F)(13). Below this temperature, any remaining unfrozen liquid between ice
crystals undergoes a "glass transition." Molecules become stuck to
their neighbors with weak hydrogen bonds. Instead of wandering about, molecules
just vibrate in one place. Without freely moving molecules, all chemistry
stops.
For living
cells to survive this process, chemicals called cryoprotectants must be added.
Cryoprotectants, such as glycerol, are small molecules that freely penetrate
inside cells and limit the percentage of water that converts into ice during
cooling. This allows cells to survive freezing by remaining in isolated pockets
of unfrozen solution between ice crystals. Below the glass transition
temperature, molecules inside these pockets lock into place, and cells remain
preserved inside the glassy water-cryoprotectant mixture between ice crystals.
This approach for
preserving individual cells by freezing was first demonstrated half a century
ago (14). It is now used routinely for many different cell types, including
human embryos. Preserving organized tissue by freezing has proven to be more
difficult. While isolated cells can accommodate as much as 80% of the water
around them turning into ice, organs are much less forgiving because there
is no room between cells for ice to grow (15).
In 1984 cryobiologist
Greg Fahy proposed a new approach to the problem of complex tissue preservation
at low temperature (16). Instead of freezing, Fahy proposed loading tissue with
so much cryoprotectant that ice formation would be completely prevented at all
temperatures. Below the glass transition temperature, entire organs would
become a glassy solid (a solid with the molecular structure of a liquid), free
of any damage from ice. This process was called "vitrification".
Preservation by vitrification, first demonstrated for embryos (2), has now been
successfully applied to many different cell types and tissues of increasing
complexity.
It is useful to
distinguish between reversible vitrification and morphological vitrification.
Reversible vitrification is vitrification in which tissue recovers from the
vitrification process in a viable state. Morphological vitrification is
vitrification in which tissue is preserved without freezing, with good
structural preservation, but in which key enzymes or other biomolecules are
damaged by the vitrification chemicals.
The physical chemistry of vitrification
Physical Definition
Luyet (17) wrote that
crystallization is incompatible with living systems and should be avoided
whenever possible. The cooling of small living systems at ultrahigh speeds of
freezing was considered to be possible, in that it could eliminate ice
formation and create instead a glass-like (vitreous) state. This constituted
the origin of the idea of vitrification but not, however, the beginning of the
vitrification of organs, which was unthinkable
at the rapidity of freezing and thawing demanded by Luyet.
In
contrast to slow-rate freezing protocols, during vitrification the entire
solution remains unchanged and the water does not precipitate, so no ice
crystals are formed (18).
The
physical definition of vitrification is the solidification of a solution (water
is rapidly cooled and formed into a glassy, vitrified state from the liquid
phase) at low temperature, not by ice crystallization but by extreme elevation
in viscosity during cooling (16). Fahy expressed this as follows:
"the viscosity of the sample becomes greater and greater until the
molecules become immobilized and the sample is no longer a liquid, but rather
has the properties of a solid." However, vitrification is a result of high
cooling rates associated with high concentrations of cryoprotectant.
Inevitably, this is biologically problematic and technically difficult (19).
Water
is not very viscous, therefore it can be vitrified only by an extremely rapid
"flash-freezing" of a small sample. Under such rapid cooling, water
molecules don't have time to arrange themselves into a crystalline structure.
Viscosity increases very little when water is cooled, but at freezing
temperature a sudden phase transition occurs to an ice crystal. Water can be
made to vitrify if cooled at a rate of millions of degrees Celsius per second.
Water can also vitrify if mixed with cryoprotectants. The cryoprotectant
ethylene glycol is used with water as automobile antifreeze. The cryoprotectant
propylene glycol is used to minimize ice-crystals in ice-cream. The
cryoprotectant glycerol has long been used in vitrifying human sperms and to
reduce freezing in human cryonics patients.
Vitrification of water inside cells can be achieved in two ways: 1)
increasing the speed of temperature conduction and 2) increasing the
concentration of cryoprotectant. So, by using a small volume (<1 µl) of
high-concentration cryoprotectant, and very rapid cooling rates from 15 000 to
30 000°C/min, vitrification could be achieved (20).
The
radical strategy of vitrification results in the total elimination of ice
crystal formation, both within the cells being vitrified (intracellular) and in
the surrounding solution (extracellular).
Variables
in vitrification
The two most important
parameters for the success of vitrification are:
1) The speed of the cooling and warming rates
and
2) The effects of the dissolved substances
(i.e., concentration of the cryoprotectants).
A
practical limit to attainable cooling speed exists, as does a biological limit
on the concentration of cryoprotectant tolerated by the cells during
vitrification. Therefore, a balance between the maximization of cooling rate
and the minimization of cryoprotectant concentration is important.
Cooling and warming rates
The
main benefit of an increase cooling and warming rate is the decreased
concentration of cryoprotectant solutions, which would subsequently decrease
toxic and osmotic injury. Another advantage is the quick passage through the
dangerous temperature zones between + 15 and - 5 °C to decrease the chilling
injury. This is especially important in the case of sensitive objects such as
lipid rich structures (including pig embryos), oocytes and pre-compaction stage
embryos.
The
optimal cooling rate is that which permits the most water to move out of the
cells and to freeze/vitrify extracellularly. Therefore, a primary strategy of
any vitrification protocol must be to pass rapidly through the critical
temperature zone. The LN2 at -196°C (point of vaporization) is at the boiling
point. As cells are immersed into LN2, the LN2 is warmed, and this induces
extensive boiling (so that nitrogen gas is produced). At this point,
evaporation occurs, and a vapor coat forms around the cells. As a result, the
vapor surrounding the cells can create effective insulation that cuts down
temperature transfer, and this results in a decreased cooling rate.
There are three
practical ways to increase cooling and warming rates: to minimize the volume of
the solution surrounding the oocytes and embryos; to minimize the
thermo-insulation, preferably by establishing a direct contact between the
cryoprotectant solution and the liquid nitrogen; and to avoid liquid nitrogen
vapor formation.
Theoretically, the
simplest solution is to drop the cryoprotectant solution directly into the
liquid nitrogen. However, this method has several disadvantages. To form a
drop, a rather high amount of the solution is required. Moreover, the drop will
float for a long period of time over the surface of the liquid nitrogen, as the
result of evaporation of the nitrogen, consequently the cooling rate will be
rather low. To avoid these problems, several carrier tools were developed and
will be discussed later.
Another possibility to
improve cooling and warming rates is to prevent LN2 vapor formation. Very
recently, two solutions for this problem were published. The first possibility
is to super-cool the LN2. With a short term application of vacuum over the LN2,
the temperature can be decreased to -205 or -210 °C , far below the boiling
point. This minimizing the gas coat formation around the sample and
consequently increases the cooling rate (21). The alternative solution is to
drop the embryos or oocytes onto a metal plate pre-cooled to 150°C (solid
surface vitrification)(22).
Concentration of the cryoprotectant
Cell
injury and death during freezing and thawing is related to the formation of
large amounts of ice crystals within the cells. Cryopreservation aims to remove
as much of the intracellular water as is compatible with life, before freezing,
so as to reduce the extent of intracellular ice formation to the point where it
ceases to constitute a threat to the viability of the cell. Removal of
excessive amounts of water, however, will cause cellular injury and possible
death through the effect of the resulting highly concentrated intracellular
environment on intracellular components, particularly their membranes. This is
called the `solution` effect.
Cryoprotectants are compounds that are used to achieve the required
intracellular dehydration. They do so either by entering the cell and
displacing the water molecules out of the cell (permeating cryoprotectants) or
by remaining largely out of the cell but drawing out the intracellular water by
osmosis (non-permeating cryoprotectants). Usually, combinations of the
compounds are used.
The
most common and accepted cryoprotectant for vitrification procedures is
ethylene glycol (EG). It appears to have a low toxic effect on mouse embryos
and blastocysts (23) and a rapid diffusion coupled with a quick equilibration
of EG into the cell through the zona pellucida and the cellular membrane (24).
Normal pregnancies and live
births achieved with cryopreserved oocytes and embryos in animals (25) and in
humans (26) suggesting that this molecule is a good candidate for human embryo
vitrification.
Interestingly,
Shaw et al. (27) observed that mouse pronucleate (PN), embryos and 4-cell
embryos can be frozen-thawed in either EG or 1,2-propanediol without
significant loss of viability. In contrast, Emiliani et al. (24) obtained
results from cryopreservation of pronuclear-stage and 4-cell stage embryos that
differed somewhat from those reported by Shaw et al. In their experience, EG
did not seem to be a good cryoprotectant for pronuclear-stage embryos.
To
achieve high cooling rates, the use of high concentrations of the
cryoprotectant solution is required in order to depress ice crystal formation.
A negative consequence of this is that in some cryoprotectants, this
concentration can lead to either osmotic or chemical toxicity.
Minimizing
the toxicity of the cryoprotectant resulting from the high cryoprotective
concentration can be achieved in two ways (28).
Reduction
of cryoprotectant. This is accomplished through the additional use of polymers
that are non-permeable and, therefore, remain in the extracellular area. In
addition, minimizing the toxicity of the cryoprotectant can also be achieved by
using a combination of two cryoprotectants and a stepwise exposure of cells to
pre-cooled concentrated solutions.
By
reducing the amount of cryoprotectants required, the toxic and osmotic effects
of them are also decreased. Furthermore, by increasing cooling and warming
rates, it is possible to reduce the cryoprotectant concentration and, thus,
toxicity.
A
common practice to reduce the toxicity of the cryoprotectant, but not its
effectiveness, is to place the cells first in a solution of lower-strength EG
to partially load the cells with EG before transferring them to the
full-strength EG/disaccharide mixture. In addition, the vitrification solution
often may contain an almost equi-molar combination of EG and DMSO.
A very recent study has
shown that the higher cooling rate using the nylon loop allows an apparently
beneficial reduction in the concentration of the cryoprotectant (29).
Increasing the hydrostatic pressure of
the solution.
Kanno
et al. (30) were able to demonstrate that the temperature at which
crystallization begins (Th, the "ice nucleation
temperature") can be reduced through an increase in the hydrostatic
pressure. The "glass transition temperature" (Tg, the temperature at
which the transition to vitreous condition begins) rises with increased
pressure (31). This allows a transition to smaller cryoprotective
concentrations (32).
A
downside to this is that the increased pressure can cause damage to the
biological system. Dog kidneys, for example, survived a 20-min exposure to 1000
atm (33), whereas rabbit kidneys showed severe damage after only 20 min at 500
atm. However, the increased pressure is only necessary during vitrification.
Atmospheric pressure is sufficient for the subsequent storage.
With
the application of these strategies the vitrification approached or possibly
reached the efficiency of traditional freezing, but did not surpass it.
Buffering solutions and Macromolecules
Cryoprotectant
solutions contain other compounds that may have protective effects on the cells
during freezing and thawing, and they are called extenders. Examples of such
compounds include citrates, egg yolk. The cryoprotectant solution is usually
made by adding measured amounts of these compounds to physiological solutions
similar to gamete and embryo culture media. The pH of the cryoprotectant
solution is maintained by using HEPES or phosphate buffers. Egg yolk is only used
as an extender in sperm cryopreservation media.
Buffering Solutions
Vitrification solutions
are aqueous cryoprotectant solutions that do not freeze when cooled at high
cooling rates to very low temperature. Therefore, the buffered medium base used
for vitrification is either phosphate-buffered saline or Hepes-buffered culture
medium such.
Disaccharides
The addition of a sugar
(sucrose, glucose, fructose, sorbitol, saccharose, trehalose, or raffinose) to
an EG-based vitrification solution influenced the overall properties of the
solution (34), so the properties of the sugar in the establishment or
modification of a vitrification solution need to be taken into consideration.
Additives with large molecular weights, such as disaccharides like sucrose or trehalose, do not penetrate the cell
membrane, but they can significantly reduce the amount of cryoprotectant
required as well as the toxicity of EG by decreasing the concentration required
to achieve a successful cryopreservation of human oocytes and embryos. The
incorporation of non-permeating compounds into the vitrifying solution and the
incubation of the cells in this solution before any vitrification helps to
withdraw more water from the cells and lessens the exposure time of the cells
to the toxic effects of the cryoprotectants. The non-permeating sucrose also
acts as an osmotic buffer to reduce the osmotic shock that might otherwise
result from the dilution of the cryoprotectant after cryostorage(35).
Macromolecules
Cells naturally contain
high concentrations of proteins, which are helpful in vitrification. Higher
concentrations of cryoprotectants are needed for extracellular vitrification
than for intracellular vitrification. The addition of a polymer with a high
molecular weight such as polyvinylpyrrolidone (PVP), polyethylene glycol (PEG),
or Ficoll is sufficient to vitrify extracellularly with the same cryoprotective
concentration used intracellularly. Early studies evaluated the potential
beneficial effects of adding macromolecular solutes to the vitrification
solution to facilitate vitrification (36).
These polymers can
protect embryos against cryoinjury by extenuating the mechanical stresses that
occur during cryopreservation (37). They do this through modifying the
vitrification properties of these solutions by significantly reducing the
amount of cryoprotectant required to achieve vitrification itself (38). They
also influence the viscosity of the vitrification solution and reduce the
toxicity of the cryoprotectant through lowered concentrations. Furthermore, the
polymers may be able to build a viscous matrix for encapsulation of the
oocytes/embryos and prevent crystallization during cooling and warming (39,
40).
Sample size and carrier systems
To
improve the chances that the sample is surrounded by liquid and not vapor, the
sample size should be minimized so that the duration of any vapor coat is
reduced and the cooling rate is increased. Furthermore, to facilitate
vitrification by even higher cooling rates, it is also necessary to minimize
the volume of the vitrification solution as much as practical. To minimize the
volume of the vitrification solution, special carriers are used during the
vitrification process. These include the open pulled straws (41), the
flexipet-denuding pipette (FDP) (42), microdrops (43), electron-microscopic
(EM) copper grids (44), hemistraw system (45), small nylon coils (46), or nylon
mesh (47), the cryoloop (48), and the minimum volume cooling (MVC) using the
cryotop (49).
These
have all been used as carriers or vessels to achieve higher cooling rates.
These methods have led to positive results for the vitrification of embryos
from species with a high sensitivity to damage from freezing as well as in the
equally sensitive human and mouse oocytes. Even the vitrification of human
embryonic stem cells proved to be effective.
Comparative results of carrier systems
The OPS
vitrification method (5) has been successfully applied to the cryopreservation
of matured bovine oocytes, precompaction- and preimplantation-stage bovine
embryos (50), and mature mouse as well as human oocytes (51, 52).
More recently,
successful pregnancies and deliveries after using the OPS, Cryoloop, or French
ministraws in vitrification protocols for human oocytes, Day 3 embryos, and
blastocysts have been reported (34, 7, 26, 53, 54).
Furthermore, the
efficacy of a rapid cryostorage method using the flexipet-denuding pipette
(FDP) for human PN embryo s has also been reported (42). In this study, the
overall survival rate of PN embryos (1PN and 3PN) after warming was 87.5%. The
overall percentage of warmed zygotes that cleaved and reached the 2-cell stage
did not differ from that in the control groups (77% vs. 85%). Finally, comparing the developmental potential up
to cavitation and blastocyst formation on Day 5, the overall outcome of the
vitrified PN was 31%, compared to 33% for the control groups (52).
In
addition, using EM grids, bovine oocytes and blastocysts (4, 55) as well as
human multipronuclear zygotes have been successfully vitrified (56).
Interestingly, a new
vitrification device called the VitMaster is able to slightly decrease the
temperature of LN2 to between -205 and -208°C (compared to -196°C). This is
achieved by creating a partial vacuum; thereby, it increases significantly the
cooling rate by using LN2 slush. This vitrification device was first introduced
by Arav et al. (21) [Arav A. et al, 2000] and has been used very successfully
for bovine, ovine, and human oocyte vitrification.
Encouraging results were
obtained by using the minimum volume cooling (MVC) technique using the cryotop
carrier system created by Kuwayama. They reported that they performed more than
15,000 cases of virtification over a period
of four years on human oocytes, 2PN, 4 cell stage embryos as well as human
blastocysts. Survival rates higher than 90% and high pregnancy rates following
development of in vitro culture and embryo transfer were obtained regardless of
the stage (49, 57).
There was a report of
possible embryo infection after exposure to LN2 artificially mixed with high
concentrations of virus. Nevertheless, because it is highly unlikely such an
adverse environment exists and actual cases of contamination have not occurred
in previous surveys, there is hardly any concern in real terms. However, in
some countries like USA, legal provisions are
beginning to be considered for the future to avoid such a risk.
Viral infection mediated
by LN2 can be prevented by completely sealing the cryopreservation container
prior to immersing the sample in LN2. Kuwayama et al (57, 58) developed a
vitrification method for this purpose, the vitritip method, which is able to
realize complete sealing of the container along with ultra-rapid cooling and
warming rates comparable to the Cryotop method. Kim et al. (59) used pulled
straws for oocyte vitrification and they stated that this method provides a
simple, rapid and effective strategy for preventing the risk of LN2
contamination during storage.
To
date, however, vitrification as a cryopreservation method has had very little
practical impact on human assisted reproduction, and human pre-implantation
embryo vitrification is still largely experimental. Inconsistent survival rates
have been reported, and one explanation could be that such a variety of
different carriers or vessels have been used for vitrification. Second, so many
different vitrification solutions have been formulated that this has not helped
to focus efforts on perfecting a single approach. On the other hand, the
reports of successfully completed pregnancies following vitrification are
encouraging for further research. Clearly, attention needs to be paid to the
inconsistent survival rates following vitrification, and work toward continuing
improvements should be ongoing.
Intracellular Lipids as a "Stumbling
Block" for vitrification
Data
regarding a particularly interesting method of oocyte and embryo
cryopreservation have been published (60, 61). This method consists of the
polarization and removal of cytoplasmic lipids from oocytes or embryos before
vitrification. Nagashima et al. (62), Using this method, those authors avoided
a negative aftereffect caused by the cooled intracellular lipids. The removal
of intracellular lipids did not adversely affect the further development of
oocytes and embryos. Successful oocyte vitrification after removal of
cytoplasmic lipids leads to the question of changes in the physicochemical
properties of cytoplasmic membrane lipids arising at low temperatures (63).
We do, however, believe
that it is impossible to dismiss classic data regarding the role of
intracellular lipids as an energy source for oocytes [(64) and as building
materials for membranes of future embryos. That is confirmed by the increased
volume of mitochondria as well as lipid vesicles increases during oocyte
development to the metaphase II stage (65).
It is known that MII
oocytes are more resistant to freeze-damage than GV-stage oocytes. We consider
that this may be due to differences in the properties of cytoskeletal elements.
One important difference is that the configuration of microtubules and
microfilaments is different during these two stages of oocyte maturation.
Cytoskeleton elements in GV-stage oocytes appear straight and rigid, whereas
microfilaments and microtubules in MII-stage oocytes appear undulating and
flexible (66). Given the hypothesis that the interaction between the lipid
phase of cells and the elements of the cytoskeleton is complex, hardening of
these lipids might cause deformation and disruption of the cytoskeleton. In the
case of the rigid GV-oocyte cytoskeleton, this apparently results in permanent
damage, whereas in the more flexible MII-oocyte cytoskeleton, permanent damage
is absent.
Therefore,
on the one hand, the lipids are a "stumbling block" during oocyte
cryopreservation, but on the other hand, their role in the vital activity of
cells as energy and building materials is important.
Vitrification of oocytes
Although
human oocytes have been successfully cryopreserved using traditional slow-rate
or equilibrium freezing protocols and pregnancies reported (67, 68, 69, 70,
71), the inconsistent results have limited the application of clinical
cryopreservation of oocytes as a routine technique. To survive
cryopreservation, the oocyte must tolerate a sequence of volumetric contractions
and expansions. Unlike all stages of preimplantation human embryos, oocytes are
more vulnerable to the cryopreservation procedures involving ice
crystallization. This can be explained by the decrease in permeability of the
cytoplasmic membranes of oocytes (72).
It
is well known that the sensitivity of oocytes to osmotic swelling, which can
occur during the removal of cryoprotectant from cryopreserved cells, is very
high. Furthermore, cryopreserved cells just after warming are more sensitive
than fresh ones to osmotic swelling (73).
However, mouse, bovine,
equine, and human oocytes can survive cryopreservation by vitrification (74).
Furthermore, human oocytes are able to develop to the blastocyst stage and
continue on to birth following vitrification. The results from recent studies
highlight that the high cooling rate is an important factor to improve the
effectiveness of oocyte vitrification.
Vitrification of zygotes
The
efficacy of a rapid freezing method using the EM copper grid or the FDP for
human PN embryos has already been reported (42, 56). With respect to survival,
cleavage on Day 2, and blastocyst formation, a high survival and cleavage rate
of multipronuclear zygotes was also documented (45, 56). Liebermann et al.,
using 5.5 M EG, 1.0 M sucrose, and an FDP as a carrier for the vitrification,
observed 90% of 2PN survival after warming and 82% of 2PN cleavage on Day 2. On
Day 3 in the vitrified 2PN group, approximately 80% of embryos cleaved to
become an embryo with four or more blastomeres, and 30% of 2PN embryos
eventually became blastocysts.
More recently, successful
pregnancies after vitrification of human zygotes have been reported (75, 53).
It is stated that the pronuclear stage is well able to withstand the
vitrification and warming conditions. Probably, this might be due to the
processes during and after the fertilization, such as the cortical reaction and
subsequent zona hardening that may give the ooplasmic membrane more stability
to cope with the low temperature and osmotic changes. Finally, the low toxicity
of EG, together with the good survival, cleavage, blastocyst formation, and pregnancy
rates obtained after vitrification of pronuclear zygotes, may satisfy the real
need in countries where cryopreservation of later-stage human embryos is not
allowed by law or for ethical reasons.
Vitrification of cleaved embryos and
blastocysts
During
embryonic development different parameters can be assessed, such as zygote
morphology, cleavage speed, embryonic morphology on the second and the third
day. The culture of embryos till day 5 allows us to use these parameters to
select the embryo(s) with the best implantation chance and allows us to limit
the number of transferred embryos to one or two. This policy decreases the
number of multiple pregnancies without losing the actual pregnancy rates but
confronts us with the task of freezing the more complex blastocyst. Therefore
we need an efficient and reliable method to freeze blastocyst.
The OPS vitrification
method (5) has been successfully applied to the cryopreservation of matured
bovine precompaction- and pre-implantation-stage embryos (50).
More
recently, successful pregnancies and deliveries after using the OPS, cryoloop,
or 0.25-ml French straws in vitrification protocols of human Day 3 embryos and
blastocysts have been reported (26, 76, 77, 78).
Hiaso
Osada et al. (79) studied the clinical efficiency of vitrification using the
Cryotop method by comparing the pregnancy rates after transfer of vitrified and
fresh blastocysts from 752 patients. One thousand one hundred fifty six
blastocysts were obtained from 3031 oocytes after culture and 580 blastocysts
were vitrified, of these blastocysts, 572(98.6%) survived after thawing, and
572 (100%) transferred to the patients. 55.6% (275/495) became pregnant, and
the total number of blastocysts per transfer was 1.16. On the other hand, 576
fresh blastocyst were transferred to 483 patients (1.19 blastocysts per
patient) and the pregnancy rate was 30.8% (149/483). The pregnancy rate of the
vitrification group was significantly higher than those in the fresh blastocyst
group.
Factors affecting blastocyst
vitrification
Artificial shrinkage
A major factor that can
affect the survival rate of blastocysts is that the blastocyst consists of a
fluid-filled cavity called the blastocoele. The likelihood of ice crystal
formation is directly proportional to the volume and inversely proportional to
the viscosity and the cooling rate. A decrease in survival rate after
vitrification was noted when the volume of the blastocoelic cavity increased.
Therefore, it should be assumed that an insufficient permeation of EG inside
the cavity might allow ice crystal formation during the cooling step, reducing
the post-warming survival. Intrablastocoelic water, which is detrimental to
vitrification, may remain in the cavity after a 3-min exposure to EG solution.
Vanderzwalmen et al. 78 [Vanderzwalmen P et al 2002] showed that survival rates
in cryopreserved, expanded blastocysts could be improved by artificial
reduction of the blastocoelic cavity with a needle or pipette before
vitrification.
Assisted hatching is beneficial
After thawing and
dilution in a sucrose bath, the blastocyst is incubated for 24 hours before
transfer. This allows the assessing of their re-expansion and survival.
Vanderzwalmen et al. observed that a higher implantation rate of spontaneously
hatching or hatched blastocysts as compared to expanded blastocysts which were
still surrounded by intact zona pellucida. To facilitate the hatching process
they started to mechanically open the zona pellucida after thawing. They
observed a higher implantation rate after assisted hatching. That reinforces
the hypothesis that vitrification hardens the zona pellucida and inhibits
spontaneous hatching in some cases (80).
Influence of early embryonic quality
The quality of the
development of the early embryo determines the quality of the blastocyst and
the final result. The blastocysts which originate from a cohorts of early
embryos of optimal quality had survival rates, implantation rates and ongoing
pregnancy rates of respectively 73%, 32% and 19% (80).
In
contrast, when the blastocysts came from embryos of sub-optimal quality, the
rates of survival, implantation and ongoing pregnancy were only 38%, 9% and 6%.
This underline the importance of following day by day the development of each
embryo, and to select the blastocyst with the best potential for vitrification.
Vitrification of ovarian tissue
The problems related to
successful cryopreservation increase with the complexity of the sample intended
for vitrification. The main problems in the vitrification of large samples are
fracturing as well as crystallization during cooling. Fracturing can be mostly
prevented through careful handling of the sample, so that crystallization
remains the more serious problem (81).
Various research groups
have reported the successful vitrification of ovarian tissue from mice, rats,
Chinese hamsters, rabbits, Japanese apes, cows, and human fetuses (82-88).
Vital follicles were still detected 4 days after the warming of vitrified fetal
rat ovaries. Miyamoto and Sugimoto (89) vitrified rat ovaries and removed the
cryoprotectant stepwise. The histological examination of the follicles yielded
positive results in surface area but revealed degenerative changes, such as
pyknosis, vacuolization, and cell swelling, in the other remaining tissue.
Therefore, "slow cooling" was considered to be superior, even though
the tissue showed a partial vitality. The comparison of conventional freezing
and vitrification of bovine ovarian tissue demonstrated, however, that a
vitrification protocol (exposure to 5.5 M EG at 22°C for 20 min) could be just
as effective as "slow freezing" (90).
Initial
studies concerned the vitrification of human ovarian tissue. Comparable results
after vitrification were found in a computer-aided image analysis of cell
nuclei (91).
It
is known from other areas of research that the vitrification of cornea (92) and
vessels (93, 94) is possible. Practical knowledge regarding vitrification of
human ovarian tissue by means of direct plunging in LN2 is limited. To our
knowledge, only a few publications concern the successful vitrification of
human fetal (95) and adult ovarian tissue samples using EG and saccharose.
Rahimi et al. stated that,
the histological studies of vitrified human adult ovarian tissue samples
(maximum size, 1 mm3) showed that freezing and warming with EG + saccharose +
egg yolk in combination with direct plunging of straws or grids in LN2 did not
influence the ovarian tissue morphology or the follicle morphology
significantly. In combination with suitable long-term cultures of human ovarian
tissue, the subsequent in vitro maturation could complement treatment in
planned transplants (96).
Vitrification of spermatozoa
The first attempts at
cryopreservation of spermatozoa were performed during the 1940s (14). The
empirical methods developed during the 1950s are still used today. The motility
of cryopreserved/thawed spermatozoa normally falls to approximately 50% of the
motility before freezing. Despite routine application, the problem of toxicity
due to osmotic stress during saturation and dilution of the cryoprotectant as
well as the possible negative influence on the genetic material is as yet
unresolved (97-99).
Stepwise saturation and
dilution can minimize the negative consequences of osmotic stress. In practice,
current results are acceptable, but the procedures are still altogether
relatively difficult and simplification desirable. Besides the possible savings
in time, it should also be considered that cryoprotectants as well as
appropriate equipment are necessary. Most laboratories use programmable
freezers. The entire procedure lasts approximately 30-60 min, and in some
circumstances even longer.
Compared to the slow-freezing
method, vitrification has economic advantages, because no freezing instruments
are needed and vitrification/warming requires only a few seconds. Classical vitrification requires a high percentage
of permeable cryoprotectants in medium (30%-50%, compared to 5%-7% with slow
freezing) and is unsuitable for the vitrification of spermatozoa due to the
lethal osmotic effect. No data exist regarding the vitrification of
spermatozoa. Shape and size of the sperm head could be factors that define the
cryosensitivity of the cell.
Comparative studies (100) on various mammalian species (boar, bull, ram,
rabbit, cat, dog, horse, and human) showed a negative correlation between the
size of the sperm head and cryostability. Among the above-mentioned species, human
spermatozoa possessed the smallest size with maximal cryostability (101).
Nawroth
F. et al. (102) demonstrated that in the vitrification of human spermatozoa,
the same concentration of cryoprotectant as used in the conventional method
showed severe toxic effects. Vitrification yielded the best results with
swim-up prepared spermatozoa without cryoprotectant. In comparison to
conventional freezing with cryoprotectant, the vitrification of prepared
spermatozoa without cryoprotectant led to significantly higher motility. The
differences in morphology, recovery rate of motile spermatozoa, viability, and
acrosome reaction between the two freezing methods were irregular but, in most
cases, not significant. Spermatozoa vitrified without cryoprotectant maintained
the ability after warming to fertilize human oocytes, which developed further
into blastocysts.
CONCLUSION
Vitrification
as a cryopreservation method has many primary advantages and benefits, such as
no ice crystal formation through increased speed of temperature conduction,
which provides a significant increase in cooling rates. This permits the use of
less concentrated cryoprotectant agents so that the toxic effect is decreased.
Additionally, chilling injuries are considerably reduced. Many variables in the
vitrification process exist that can profoundly influence its effectiveness and
the potential to improve the survival rates of vitrified cells. These include: